business
Canada and India now have generic Wegovy. Here’s why the U.S. doesn’t.
Over the next year, countries that are home to 40% of the world’s population are set to get access to Ozempic and Wegovy generics that could cost as little as $15 a month.
Read full story on MarketWatch → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from MarketWatch alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop